Shofu Inc
TSE:7979
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (9.2), the stock would be worth ¥1 848.05 (8% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.5 | ¥1 706 |
0%
|
| 3-Year Average | 9.2 | ¥1 848.05 |
+8%
|
| 5-Year Average | 3.3 | ¥656.59 |
-62%
|
| Industry Average | 8.3 | ¥1 667.82 |
-2%
|
| Country Average | 8.7 | ¥1 745 |
+2%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥55.4B
|
/ |
Jan 2026
¥6B
|
= |
|
|
¥55.4B
|
/ |
Mar 2026
¥6.4B
|
= |
|
|
¥55.4B
|
/ |
Mar 2027
¥7.5B
|
= |
|
|
¥55.4B
|
/ |
Mar 2028
¥8.3B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Shofu Inc
TSE:7979
|
60.7B JPY | 8.5 | 14.3 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
63.4B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 28.4 | 39.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.5B CHF | 15 | 39 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
98.2B DKK | 13 | 24.6 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD | 14.5 | 33.3 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 12.1 | 34.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 17.4 | -16.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.4T KRW | -84.9 | -38 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
895.2B JPY | 23.9 | 50.6 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 14.9 | 23.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
Shofu Inc
Glance View
Shofu, Inc. engages in the manufacture and sale of dental materials and equipment. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 1,206 full-time employees. The firm operates in three business segments. The Dental-related segment is engaged in the manufacture and sale of prosthetic tooth materials, abrasive materials, metals, chemicals, cement, as well as various equipment and tools. The Nail-related segment is engaged in the manufacture and sale of nail care products. The Others segment is engaged in the manufacture and sale of industrial abrasives.
